NCT02112890

Study to Assess Seroprevalence of Hepatitis A, Hepatitis B and Bordetella Pertussis in Mexico

Seroprevalence of Hepatitis A, Hepatitis B and Bordetella Pertussis in Mexico

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 1,603 (actual)
• Sponsor: GlaxoSmithKline · Industry
• Sex: All
• Age: 10 Years – 25 Years
• Healthy volunteers: Accepted

Summary

This study will assess the seroprevalence of hepatitis A virus (HAV), hepatitis B virus (HBV) and Bordetella pertussis (B. pertussis) in adolescents and young adults in Mexico.

Detailed description

A random sample of subjects constituting adolescents and young adults (≥10 - ≤25 years of age) will be selected from the total population that participated in the Encuesta Nacional de Salud y Nutrición (ENSANUT) 2012 in Mexico. Data (through structured questionnaires and interviews) and stored serum samples of the selected subjects obtained from the ENSANUT 2012 will be used in this study. A subset database will be designed by the National Institute of Public Health (NIPH) for the purpose of this study. Extracted data and laboratory results of the selected subjects will be captured in this database.

Conditions

• Hepatitis A
• Viral Hepatitis Vaccines

Interventions

Type	Name	Description
OTHER	Data collection	Data of the selected subjects (through structured questionnaires and interviews) and stored serum samples obtained from the ENSANUT 2012. A subset database will be designed by the NIPH for the purpose of this study. Extracted data and laboratory results of the selected subjects will be captured in the study database.

Timeline

• Start date: 2014-12-10
• Primary completion: 2016-05-02
• Completion: 2016-05-02
• First posted: 2014-04-14
• Last updated: 2019-06-27

Locations

1 site across 1 country: Mexico